Tarceva (Physicians Total Care, Inc.)
Welcome to the PulseAid listing for the Tarceva drug offered from Physicians Total Care, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Physicians Total Care, Inc. |
NON-PROPRIETARY NAME: | erlotinib hydrochloride |
SUBSTANCE NAME: | ERLOTINIB HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-07-01 |
END MARKETING DATE: | 0000-00-00 |
Tarceva HUMAN PRESCRIPTION DRUG Details:
Item Description | Tarceva from Physicians Total Care, Inc. |
LABELER NAME: | Physicians Total Care, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2005-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54868-5290_fb809355-146a-4baf-a029-a80b7faee7bb |
PRODUCT NDC: | 54868-5290 |
APPLICATION NUMBER: | NDA021743 |
Other ERLOTINIB HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: